Core Insights - GRAIL, Inc. is focused on early cancer detection, aiming to identify cancer when it is still curable [2][4] - The company will present at the Bernstein Insights: Healthcare Leaders and Disruptors forum on September 24, 2025 [1] Company Overview - GRAIL utilizes next-generation sequencing, population-scale clinical studies, and advanced machine learning to detect multiple cancer types at earlier stages [2] - The company's platform supports various aspects of cancer care, including multi-cancer early detection, risk stratification, and treatment monitoring [2] - GRAIL is headquartered in Menlo Park, California, with additional locations in Washington, D.C., North Carolina, and the United Kingdom [2]

About GRAIL MENLO PARK, Calif., July 30, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Canaccord Genuity 45th Annual Growth Conference in Boston on Wednesday, Aug. 13 at 8:30 a.m. ET. Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at leas ...

Core Insights - GRAIL, Inc. is set to release its financial results for the second quarter of 2025 on August 12, 2025, after market close [1] - Following the financial results announcement, GRAIL management will conduct a webcast and conference call to discuss the results and business progress [1] Company Overview - GRAIL is a healthcare company focused on early cancer detection, aiming to alleviate the global burden of cancer through advanced technologies [4] - The company utilizes next-generation sequencing, population-scale clinical studies, and machine learning to identify multiple cancer types at earlier stages [4] - GRAIL's platform supports various aspects of cancer care, including multi-cancer early detection, risk stratification, and treatment monitoring [4] - The company is headquartered in Menlo Park, California, with additional locations in Washington, D.C., North Carolina, and the United Kingdom [4]

Core Viewpoint - GRAIL, Inc. is focused on early cancer detection to improve treatment outcomes and will present at the Jefferies Global Healthcare Conference 2025 [1] Company Overview - GRAIL is a healthcare company dedicated to detecting cancer early when it is most treatable [3] - The company utilizes next-generation sequencing, large-scale clinical studies, and advanced machine learning to identify multiple cancer types at earlier stages [3] - GRAIL's platform supports various aspects of cancer care, including multi-cancer early detection, risk stratification, and treatment monitoring [3] - The company is headquartered in Menlo Park, California, with additional locations in Washington, D.C., North Carolina, and the United Kingdom [3]

Core Insights - GRAIL, Inc. will release its financial results for the first quarter of 2025 on May 13, 2025, after market close [1] - A webcast and conference call will be held on the same day at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and business progress [1] Company Overview - GRAIL is a healthcare company focused on early cancer detection, utilizing next-generation sequencing, clinical studies, and machine learning [4] - The company aims to alleviate the global burden of cancer by identifying multiple cancer types at earlier stages [4] - GRAIL's platform supports various aspects of cancer care, including early detection, risk stratification, and treatment monitoring [4] - The company is headquartered in Menlo Park, California, with additional locations in Washington, D.C., North Carolina, and the United Kingdom [4]